Sana Biotechnology Inc (NASDAQ: SANA) on Friday, plunged -5.18% from the previous trading day, before settling in for the closing price of $5.3. Within the past 52 weeks, SANA’s price has moved between $1.26 and $7.30.
A company in the Healthcare sector has dropped its sales by -10.60% annually for the last half of the decade. The company achieved an average annual earnings per share of 24.25%. With a float of $145.63 million, this company’s outstanding shares have now reached $230.51 million.
Sana Biotechnology Inc (SANA) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Sana Biotechnology Inc is 43.71%, while institutional ownership is 43.51%. The most recent insider transaction that took place on Feb 18 ’25, was worth 237,000. Before that another transaction happened on Jan 16 ’25, when Company’s Officer proposed sale 75,000 for $3.86, making the entire transaction worth $289,500.
Sana Biotechnology Inc (SANA) Latest Financial update
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.27 earnings per share (EPS) for the period topping the consensus outlook (set at -0.27) by -0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 24.25% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.57% during the next five years compared to -10.60% drop over the previous five years of trading.
Sana Biotechnology Inc (NASDAQ: SANA) Trading Performance Indicators
Sana Biotechnology Inc (SANA) is currently performing well based on its current performance indicators. A quick ratio of 2.47 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.06, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.65 in one year’s time.
Technical Analysis of Sana Biotechnology Inc (SANA)
Let’s dig in a bit further. During the last 5-days, its volume was 12.87 million. That was better than the volume of 5.77 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 55.99%.
During the past 100 days, Sana Biotechnology Inc’s (SANA) raw stochastic average was set at 66.67%, which indicates a significant increase from 51.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.51 in the past 14 days, which was higher than the 0.31 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.55, while its 200-day Moving Average is $2.93. However, in the short run, Sana Biotechnology Inc’s stock first resistance to watch stands at $5.30. Second resistance stands at $5.58. The third major resistance level sits at $5.82. If the price goes on to break the first support level at $4.78, it is likely to go to the next support level at $4.54. The third support level lies at $4.26 if the price breaches the second support level.
Sana Biotechnology Inc (NASDAQ: SANA) Key Stats
Market capitalization of the company is 1.30 billion based on 237,806K outstanding shares. Right now, sales total 0 K and income totals -266,760 K. The company made 0 K in profit during its latest quarter, and -93,800 K in sales during its previous quarter.
